title: Tumor Neoangiogenesis and Flow Congestion: A Parallel to the Braess Paradox?
authors: From the Department of Dermatology, Allergy and Venereology, University of Frankfurt Medical School, Frankfurt/Main, Germany. kippenberger@em.uni-frankfurt.de.
authors: Stefan
authors: S
authors: Kippenberger
authors: From the Department of Dermatology, Allergy and Venereology, University of Frankfurt Medical School, Frankfurt/Main, Germany.
authors: Markus
authors: M
authors: Meissner
authors: From the Department of Dermatology, Allergy and Venereology, University of Frankfurt Medical School, Frankfurt/Main, Germany.
authors: Roland
authors: R
authors: Kaufmann
authors: From the Department of Dermatology, Allergy and Venereology, University of Frankfurt Medical School, Frankfurt/Main, Germany.
authors: Igor
authors: I
authors: Hrgovic
authors: From the Department of Dermatology, Allergy and Venereology, University of Frankfurt Medical School, Frankfurt/Main, Germany.
authors: Nadja
authors: N
authors: Zöller
authors: From the Department of Dermatology, Allergy and Venereology, University of Frankfurt Medical School, Frankfurt/Main, Germany.
authors: Johannes
authors: J
authors: Kleemann
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000503:physiopathology*; D059016:Tumor Microenvironment / Q000187:drug effects / Q000502:physiology*
chemical_list: D020533:Angiogenesis Inhibitors
keywords: angiostatins; bevacizumab; hypoxia-inducible factor 1, α-subunit; neoplasms; vascular endothelial growth factor A